Operator reference

Operator Blueprint

Operational architecture reference for organisations adopting HBOT services — hotels, longevity clinics, and wellness operators. The content is generic; specific equipment vendors, regulatory paths, and pricing are deliberately not covered. Local healthcare and device-safety regulations apply and may impose stricter requirements.

Equipment selection

Two principal chamber categories are used clinically:

  • Hard-shell (medical-grade) chambers — pressurise to 2.0–3.0 ATA with 100% oxygen via mask or hood. Required for FDA-approved indications and for any treatment requiring genuine hyperbaric pressure. Available in monoplace (single patient) and multiplace (multiple patients with attendant) configurations.
  • Soft-shell (mild HBOT) chambers — typically pressurise to 1.3 ATA with ambient air. Not equivalent to medical-grade HBOT for the indications covered on this site; the evidence base for therapeutic effect at 1.3 ATA is markedly weaker. Operators citing the Hadanny 2020 cognitive enhancement RCT or Zilberman-Itskovich 2022 long COVID RCT must be aware that those studies used 2.0 ATA hard-shell chambers — soft-shell deployments cannot reproduce those protocols.

Monoplace vs multiplace: monoplace chambers are smaller, lower capital cost, and require less specialised staffing. Multiplace chambers allow attendant presence for anxiety management and emergency response, accommodate more complex patients, and are standard for clinical wound-care services.

Staffing

  • Medical oversight: a designated hyperbaric medicine physician should hold accountability for indication review, pre-treatment screening sign-off, and adverse-event response.
  • Hyperbaric technician / nurse: trained in chamber operation, emergency descent procedures, and patient management. Certification standards vary by jurisdiction; UHMS publishes recognised credentialling pathways.
  • Multiplace attendants: when multiplace chambers are used, an inside attendant is required for the duration of compressed sessions.
  • Reception / scheduling: trained on contraindication screening (especially smoking, recent ear infection, current chemotherapy) so red flags are caught at booking, not at chamber-side.
9

Facility

  • Space: monoplace chambers fit a 3×6 m room; multiplace systems require dedicated suites with control room, oxygen storage, and emergency egress paths.
  • Ventilation: oxygen-rich environments require fire-load mitigation. Floor and wall materials, electrical fixtures, and HVAC must meet device-safety standards (regional codes vary; reference NFPA 99 in jurisdictions following US standards).
  • Fire safety: no synthetic textiles, no static-generating fabrics, no electronic devices inside the chamber, no oils or alcohol-based products on patients. Fire suppression must be appropriate to oxygen-enriched atmosphere.
  • Oxygen supply: medical-grade oxygen with documented purity testing. Backup supply mandatory.
  • Emergency egress: rapid-decompression capability and trained operator response within seconds.
  • Climate control: chamber temperature management to prevent patient overheating during compression.

Quality control

  • Chamber maintenance: scheduled service per manufacturer specification, with maintenance log retained.
  • Pressure-vessel inspection: typically annual; jurisdiction-specific.
  • Oxygen purity testing: periodic verification of supply purity, ideally at every gas-supply change-over.
  • Calibration: pressure gauges, oxygen sensors, timing systems — calibrated to manufacturer specification.
  • Adverse-event log: every adverse event recorded with date, session number, presentation, response, outcome.
  • Audit cadence: internal audit at least annually; external audit triggered by regulatory cycle or significant adverse event.

Patient flow and consent

  • Initial consultation: medical history, indication discussion, contraindication screening, expectation-setting (especially for wellness use).
  • Informed consent: written consent reviewing absolute and relative contraindications, common adverse events, expected protocol, scope of clinical effect (for wellness: explicit acknowledgement that programme sits outside FDA-approved indications).
  • Pre-session check: blood pressure, temperature, respiratory check, recent medication review, claustrophobia status, ear-clearance assessment.
  • In-session monitoring: continuous communication with attendant; vital sign capture for higher-risk patients.
  • Post-session check: tympanic membrane assessment, vital signs, tolerability questionnaire.
  • Follow-up cadence: midway-through and end-of-course reviews; outcome-measure capture per programme design.

Documentation

  • Per-session record: date, time started, pressure profile, duration, oxygen flow, adverse events, attendant identity, patient-reported tolerability.
  • Indication record: documented clinical rationale, evidence-tier, treating physician sign-off.
  • Outcome tracking: pre/post protocol measurements per programme design.
  • Adverse-event reporting: serious events reported per local regulatory framework.
  • Retention: medical records held per jurisdiction (typically 7–25 years).
  • Privacy: GDPR-compliant in EU and EEA; HIPAA-equivalent in the US.

This blueprint is generic operator reference. It does not constitute regulatory or device-safety advice. Local healthcare, device-safety, fire-safety, and consumer-protection regulations apply and take precedence over the guidance summarised here.